side effects bpc 157 The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety While BPC-157 is not a

If you want the broader landscape (and the list of other peptides driving search interest), see Metos internal piece: 14 Peptides Are About to Become Legal Again What This Means for Your Health. Who should consider AOD-9604 (and who shouldnt) Consider it only if your expectations are realistic AOD-9604 may be worth a conversation if you are: Already doing the fundamentals (protein, resistance training, sleep) Not seeking massive scale weight loss Looking at fat-loss support rather than appetite suppression Intolerant of GLP-1s and exploring alternatives (with the understanding that alternatives are usually less powerful) Avoid it if You have significant obesity and need a high-efficacy therapy (GLP-1/GIP class is typically far more impactful) (PubMed) Youre hoping it will melt fat without dietary alignment Your plan depends on unverified sources or research peptide suppliers Youre in a drug-tested sport environment (WADA prohibition is relevant) (wada-ama.org) Practical expectations (what most people want to know) How fast does it work

A significant US peptide manufacturing footprint

Are you curious about how your own before-and-after experience might look with consistent support

The study of peptides is not new

Your Next Step Toward Clinically Guided Peptide Therapy CJC-1295/Ipamorelin is one of the most studied peptide combinations for supporting natural growth hormone production